Cargando…

Improving Depression, and Quality of Life in Patients with Type 2 Diabetes: Using Group Cognitive Behavior Therapy

Objective: Depression is a chronic condition comorbid with diabetes type 2 that often remains untreated. Dealing with diabetes is a challenging task for patients and can lead to depression in long term. These two conditions have a negative influence on each other and on the individual’s quality of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Noroozi, Zahra, Hamidian, Sajedeh, Khajeddin, Niloofar, Mehrabi Zadeh Honarmand, Mahnaz, Zargar, Yadollah, Rashidi, Homeira, Dolatshahi, Behrooz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816918/
https://www.ncbi.nlm.nih.gov/pubmed/29472955
Descripción
Sumario:Objective: Depression is a chronic condition comorbid with diabetes type 2 that often remains untreated. Dealing with diabetes is a challenging task for patients and can lead to depression in long term. These two conditions have a negative influence on each other and on the individual’s quality of life. The purpose of this study was to investigate the effect of group cognitive behavior therapy on depression, quality of life in women with diabetes type 2. Method : We conducted a clinical trial among 30 women with diabetes type 2 comorbid with depression. The women were divided randomly into the two groups of intervention and control. Each group consisted of 15 individuals. The intervention group received 10 sessions of group cognitive behavior therapy while the control group didn’t. Results: The results suggested that group cognitive-behavior therapy decreased depression symptoms (F=72.17, p<0.001), and improved quality of life of the patients (F=8.82, p<0.05) of the intervention group compared to the control group. Conclusion: The results shows that group cognitive behavior therapy can affect depression symptoms, and consequently patients’ quality of life with diabetes type 2.